|
Intranasal insulin Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since June 2026
Also known as: Actrapid
Pipeline
Phase 2: 1Phase 2/3: 1
Top Sponsors
- Rutgers, The State University of New Jersey2
Indications
- Brain Blood Flow1
- Alzheimer's Disease1
- Insulin Sensitivity/Resistance1
- Diabetes1
- Metabolic Syndrome1
Other1 trial
New Brunswick, New Jersey1 trial
Exercise and Intranasal Insulin in Type 2 Diabetes
Robert Wood Johnson University Hospital Clinical Research Center
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.